Mutations of the PDE5A Gene Confer a Survival Advantage in Patients with Colon Cancer

Cancer Prev Res (Phila). 2018 Jul;11(7):439-440. doi: 10.1158/1940-6207.CAPR-18-0105. Epub 2018 May 3.

Authors

Steven Lehrer¹, Peter H Rheinstein², Kenneth E Rosenzweig²

Affiliations

¹ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. steven.lehrer@mssm.edu.
² Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 29724712
DOI: 10.1158/1940-6207.CAPR-18-0105

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Colonic Neoplasms*
Colorectal Neoplasms*
Cyclic Nucleotide Phosphodiesterases, Type 5
Humans
Inflammation
Mice
Mutation
Sildenafil Citrate

Substances

Sildenafil Citrate
Cyclic Nucleotide Phosphodiesterases, Type 5
PDE5A protein, human